GBT Annual D&A
$8.62 M
-$2.21 M-20.39%
31 December 2021
Summary:
As of February 5, 2025, GBT annual depreciation & amortization is $8.62 million, with the most recent change of -$2.21 million (-20.39%) on December 31, 2021. During the last 3 years, it has risen by +$4.01 million (+87.02%).GBT Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GBT Quarterly D&A
$2.31 M
+$40.00 K+1.77%
30 June 2022
Summary:
As of February 5, 2025, GBT quarterly depreciation & amortization is $2.31 million, with the most recent change of +$40.00 thousand (+1.77%) on June 30, 2022. Over the past year, it has increased by +$137.00 thousand (+6.32%).GBT Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GBT TTM D&A
$8.98 M
+$137.00 K+1.55%
30 June 2022
Summary:
As of February 5, 2025, GBT TTM depreciation & amortization is $8.98 million, with the most recent change of +$137.00 thousand (+1.55%) on June 30, 2022. Over the past year, it has increased by +$102.00 thousand (+1.15%).GBT TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
GBT Depreciation And Amortization Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -20.4% | +6.3% | +1.1% |
| 3 y3 years | +87.0% | +4.5% | -9.6% |
| 5 y5 years | +419.7% | +738.2% | -9.6% |
GBT Depreciation And Amortization High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -20.4% | -30.3% | -23.2% |
Global Blood Therapeutics Depreciation And Amortization History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2022 | - | $2.31 M(+1.8%) | $8.98 M(+1.5%) |
| Mar 2022 | - | $2.27 M(+2.1%) | $8.84 M(+2.6%) |
| Dec 2021 | $8.62 M(-20.4%) | $2.22 M(+1.3%) | $8.62 M(-8.3%) |
| Sept 2021 | - | $2.19 M(+1.0%) | $9.39 M(+5.9%) |
| June 2021 | - | $2.17 M(+6.2%) | $8.88 M(-10.7%) |
| Mar 2021 | - | $2.04 M(-31.9%) | $9.93 M(-8.2%) |
| Dec 2020 | $10.82 M(+9.0%) | $3.00 M(+79.6%) | $10.82 M(-2.8%) |
| Sept 2020 | - | $1.67 M(-48.3%) | $11.13 M(-4.8%) |
| June 2020 | - | $3.23 M(+10.1%) | $11.69 M(+9.6%) |
| Mar 2020 | - | $2.93 M(-11.3%) | $10.67 M(+7.4%) |
| Dec 2019 | $9.93 M(+115.6%) | $3.31 M(+48.5%) | $9.93 M(+13.8%) |
| Sept 2019 | - | $2.23 M(+1.0%) | $8.72 M(+13.8%) |
| June 2019 | - | $2.21 M(+0.5%) | $7.66 M(+25.0%) |
| Mar 2019 | - | $2.19 M(+4.6%) | $6.13 M(+33.1%) |
| Dec 2018 | $4.61 M | $2.10 M(+79.8%) | $4.61 M(+45.8%) |
| Sept 2018 | - | $1.17 M(+73.7%) | $3.16 M(+32.1%) |
| June 2018 | - | $672.00 K(+0.3%) | $2.39 M(+19.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2018 | - | $670.00 K(+3.1%) | $2.00 M(+20.3%) |
| Dec 2017 | $1.66 M(+42.9%) | $650.00 K(+62.5%) | $1.66 M(+24.9%) |
| Sept 2017 | - | $400.00 K(+45.5%) | $1.33 M(+6.3%) |
| June 2017 | - | $275.00 K(-17.4%) | $1.25 M(-0.2%) |
| Mar 2017 | - | $333.00 K(+4.4%) | $1.25 M(+7.8%) |
| Dec 2016 | $1.16 M(+32.9%) | $319.00 K(-0.6%) | $1.16 M(+4.7%) |
| Sept 2016 | - | $321.00 K(+15.5%) | $1.11 M(+10.4%) |
| June 2016 | - | $278.00 K(+14.9%) | $1.00 M(+7.7%) |
| Mar 2016 | - | $242.00 K(-9.4%) | $932.00 K(+6.8%) |
| Dec 2015 | $873.00 K(+31.1%) | $267.00 K(+23.0%) | $873.00 K(+11.5%) |
| Sept 2015 | - | $217.00 K(+5.3%) | $783.00 K(+6.7%) |
| June 2015 | - | $206.00 K(+12.6%) | $734.00 K(+6.2%) |
| Mar 2015 | - | $183.00 K(+3.4%) | $691.00 K(+3.8%) |
| Dec 2014 | $666.00 K(+24.7%) | $177.00 K(+5.4%) | $666.00 K(+36.2%) |
| Sept 2014 | - | $168.00 K(+3.1%) | $489.00 K(+52.3%) |
| June 2014 | - | $163.00 K(+3.2%) | $321.00 K(+103.2%) |
| Mar 2014 | - | $158.00 K | $158.00 K |
| Dec 2013 | $534.00 K | - | - |
FAQ
- What is Global Blood Therapeutics annual depreciation & amortization?
- What is the all time high annual D&A for Global Blood Therapeutics?
- What is Global Blood Therapeutics annual D&A year-on-year change?
- What is Global Blood Therapeutics quarterly depreciation & amortization?
- What is the all time high quarterly D&A for Global Blood Therapeutics?
- What is Global Blood Therapeutics quarterly D&A year-on-year change?
- What is Global Blood Therapeutics TTM depreciation & amortization?
- What is the all time high TTM D&A for Global Blood Therapeutics?
- What is Global Blood Therapeutics TTM D&A year-on-year change?
What is Global Blood Therapeutics annual depreciation & amortization?
The current annual D&A of GBT is $8.62 M
What is the all time high annual D&A for Global Blood Therapeutics?
Global Blood Therapeutics all-time high annual depreciation & amortization is $10.82 M
What is Global Blood Therapeutics annual D&A year-on-year change?
Over the past year, GBT annual depreciation & amortization has changed by -$2.21 M (-20.39%)
What is Global Blood Therapeutics quarterly depreciation & amortization?
The current quarterly D&A of GBT is $2.31 M
What is the all time high quarterly D&A for Global Blood Therapeutics?
Global Blood Therapeutics all-time high quarterly depreciation & amortization is $3.31 M
What is Global Blood Therapeutics quarterly D&A year-on-year change?
Over the past year, GBT quarterly depreciation & amortization has changed by +$137.00 K (+6.32%)
What is Global Blood Therapeutics TTM depreciation & amortization?
The current TTM D&A of GBT is $8.98 M
What is the all time high TTM D&A for Global Blood Therapeutics?
Global Blood Therapeutics all-time high TTM depreciation & amortization is $11.69 M
What is Global Blood Therapeutics TTM D&A year-on-year change?
Over the past year, GBT TTM depreciation & amortization has changed by +$102.00 K (+1.15%)